NR3C1 and breast carcinoma: In a landmark paper by Obradović et al., it was shown that mice with breast cancer metastasis have increased plasma levels of endogenous GCs, compared to mice with no metastasis, and this is concomitant with glucocorticoid receptor (GR) activation in tumours [9].